A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-infection schedule

C. Allegra,J. Jenkins,R. Weiss,F. Balis,J. Drake,J. Brooks,Rosely Thomas,G. Curt
DOI: https://doi.org/10.1007/BF00177251
1990-05-01
Investigational New Drugs
Abstract:
What problem does this paper attempt to address?